Clinical trials of therapies for heart failure (HF) are usually performed in patients with left ventricular systolic dysfunction (LVSD) and reduced left ventricular ejection fraction (LVEF). The ...

Because life expectancy and the prevalence of risk factors such as hypertension, obesity and diabetes are rising globally, heart failure (HF) is growing into a major health problem. Impairment of left ...

In patients undergoing coronary artery bypass graft (CABG) surgery for ischemic cardiomyopathy, adjunctive cardiac shockwave therapy (SWT) improved left ventricular ejection fraction (LVEF) in the ...

Credit: Getty Images Worsening renal function may be associated with left ventricular ejection fraction in patients with acute heart failure. Worsening renal function (WRF) may be associated with left ...

Heart failure is a complex clinical syndrome affecting around 70 million individuals globally. It has a prevalence of 2% in Europe and North America and approximately 1% in Asia and South America.

Cardiomyopathy is the leading cause of mortality in patients with DMD. Compared with their healthy counterparts, patients with DMD — including those with preserved left ventricular ejection fraction ...

Right ventricular systolic function evaluated through VO2 max is a more accurate measure of functional capacity of persons with heart failure compared with left ventricular systolic function. This ...

Please provide your email address to receive an email when new articles are posted on . 4D model-guided cardiac resynchronization lead placement improved left ventricular function vs. standard care.

LBBB is linked to electrical abnormalities, causing inefficient heart pumping, dilation, and systolic dysfunction. The study found LBBB associated with increased heart failure risk, surpassing other ...